These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26676906)

  • 1. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.
    Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS
    J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
    Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
    J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
    Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
    Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
    Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
    Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
    Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
    Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
    Bao M; Li H; Li J
    BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
    Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
    Kopel T; Kaufman JS; Hamburg N; Sampalis JS; Vita JA; Dember LM
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1588-1594. PubMed ID: 28784655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA).
    Meyer KA; Benton TZ; Bennett BJ; Jacobs DR; Lloyd-Jones DM; Gross MD; Carr JJ; Gordon-Larsen P; Zeisel SH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
    Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
    Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.